Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia.

Cerimele JM, Stern AP, Jutras-Aswad D.

Am J Psychiatry. 2010 Mar;167(3):353. doi: 10.1176/appi.ajp.2009.09101456. No abstract available.

PMID:
20194494
2.

Caffeine-induced psychiatric manifestations: a review.

Wang HR, Woo YS, Bahk WM.

Int Clin Psychopharmacol. 2015 Jul;30(4):179-82. doi: 10.1097/YIC.0000000000000076. Review.

PMID:
25856116
3.

Transient psychotic relapse temporally related to ingestion of an "energy drink".

Menkes DB.

Med J Aust. 2011 Feb 21;194(4):206. No abstract available.

PMID:
21401467
4.

An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.

Jacobs E, Fujii D, Schiffman J, Bello I.

Cogn Behav Neurol. 2008 Jun;21(2):98-103. doi: 10.1097/WNN.0b013e31816bdf90.

PMID:
18541986
5.

Caffeine-induced psychosis.

Hedges DW, Woon FL, Hoopes SP.

CNS Spectr. 2009 Mar;14(3):127-9.

PMID:
19407709
6.

Possible case of allopurinol causing relapse of psychosis.

Gomberg R.

Schizophr Res. 2007 Jul;93(1-3):409. Epub 2007 Mar 27. No abstract available.

PMID:
17389149
7.

Dependence and chronic psychosis with D-nor-pseudoephedrine.

Alevizos B.

Eur Psychiatry. 2003 Dec;18(8):423-5. No abstract available.

PMID:
14680722
8.

Does consumption of high-caffeine energy drinks affect blood pressure?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2006 Oct;8(10):744-5. No abstract available.

9.

Cannabis and the PSE.

Thomas H.

Br J Psychiatry. 1993 Feb;162:271-2. No abstract available.

PMID:
8435708
10.

Safety issues associated with commercially available energy drinks.

Clauson KA, Shields KM, McQueen CE, Persad N.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):e55-63; quiz e64-7. doi: 10.1331/JAPhA.2008.07055. Review.

PMID:
18595815
11.

Improvement of torticollis with quetiapine in a schizophrenia patient.

Flynn SW.

Can J Psychiatry. 2004 Feb;49(2):152. No abstract available.

PMID:
15065752
12.

Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.

Hewlett P, Smith A.

Hum Psychopharmacol. 2007 Aug;22(6):339-50.

PMID:
17514640
13.

Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.

Hollander E.

CNS Spectr. 2009 Mar;14(3):116-7. No abstract available.

PMID:
19407706
14.

Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.

Hofer A, Fleischhacker WW, Hummer M.

J Clin Psychiatry. 2003 Oct;64(10):1267-8. No abstract available.

PMID:
14658980
15.

Energy drinks for children and adolescents.

Oddy WH, O'Sullivan TA.

BMJ. 2009 Dec 10;339:b5268. No abstract available.

PMID:
20008969
16.

Neuroleptic withdrawal psychosis in Tourette's disorder.

Silva RR, Friedhoff AJ, Alpert M.

Biol Psychiatry. 1993 Sep 1;34(5):341-2. No abstract available.

PMID:
8104510
17.

Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports.

Chong SA, Tan CH, Lee HS.

J Clin Psychopharmacol. 1997 Feb;17(1):68-9. No abstract available.

PMID:
9004072
18.

Unjustified Concerns about Energy Drinks.

Verster JC, Alford C.

Curr Drug Abuse Rev. 2011 Mar;4(1):1-3. No abstract available.

PMID:
21466503
19.

Chronic schizophrenia-like states in methamphetamine psychosis.

Tomiyama G.

Jpn J Psychiatry Neurol. 1990 Sep;44(3):531-9.

PMID:
2074612
20.

[Caffeine--common ingredient in a diet and its influence on human health].

Wierzejska R.

Rocz Panstw Zakl Hig. 2012;63(2):141-7. Review. Polish.

Supplemental Content

Support Center